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Abstract
DNA double-strand breaks (DSBs) are highly toxic DNA lesions that can lead to chro-
mosomal instability, loss of genes and cancer. The MRE11/RAD50/NBN (MRN) com-
plex is keystone involved in signaling processes inducing the repair of DSB by, for
example, in activating pathways leading to homologous recombination repair and
nonhomologous end joining. Additionally, the MRN complex also plays an important
role in the maintenance of telomeres and can act as a stabilizer at replication forks.
Mutations in NBN and MRE11 are associated with Nijmegen breakage syndrome
(NBS) and ataxia telangiectasia (AT)-like disorder, respectively. So far, only one single
patient with biallelic loss of function variants in RAD50 has been reported presenting
with features classified as NBS-like disorder. Here, we report a long-term follow-up
of an unrelated patient with facial dysmorphisms, microcephaly, skeletal features,
and short stature who is homozygous for a novel variant in RAD50. We could show
that this variant, c.2524G > A in exon 15 of the RAD50 gene, induces aberrant splic-
ing of RAD50 mRNA mainly leading to premature protein truncation and thereby,
most likely, to loss of RAD50 function. Using patient-derived primary fibroblasts, we
could show abnormal radioresistant DNA synthesis confirming pathogenicity of the
identified variant. Immunoblotting experiments showed strongly reduced protein
levels of RAD50 in the patient-derived fibroblasts and provided evidence for a mark-
edly reduced radiation-induced AT-mutated signaling. Comparison with the previ-
ously reported case and with patients presenting with NBS confirms that RAD50
mutations lead to a similar, but distinctive phenotype.
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1 | INTRODUCTION
Damage to DNA can result in a variety of chemical changes, ranging
from base mismatches to double-strand breaks (DSBs) (Chatterjee &Aviël Ragamin and Gökhan Yigit contributed equally to this study.
Received: 24 November 2019 Revised: 24 February 2020 Accepted: 9 March 2020
DOI: 10.1002/ajmg.a.61570
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals, Inc.
Am J Med Genet. 2020;1–9. wileyonlinelibrary.com/journal/ajmga 1
Walker, 2017). DSBs in particular can lead to loss of genes, chromo-
somal instability, and cancer (Aparicio, Baer, & Gautier, 2014). DSBs
are toxic lesions that occur as a result of, for example, ionizing radia-
tion or mishaps at the replication fork (Mehta & Haber, 2014). To
repair DSBs and restore genomic integrity, eukaryotic cells have
developed two major pathways: homologous recombination repair
(HRR) and nonhomologous end joining (NHEJ). The MRE11A/RAD50/
NBN (MRN) complex is involved in both, HRR and NHEJ (Hoa et
al., 2016; Kobayashi, Antoccia, Tauchi, Matsuura, & Komatsu, 2004;
Yang et al., 2006). It consists of highly conserved proteins of which
MRE11A and RAD50 can be found even in lower eukaryotes such as
yeasts (Chamankhah & Xiao, 1999). The importance of the MRN com-
plex is highlighted by the fact that null mutations are incompatible
with life in mice, and deficiency leads to severe defects in the ability
to repair DNA (Luo et al., 1999; Xiao & Weaver, 1997; Zhu, Petersen,
Tessarollo, & Nussenzweig, 2001). The MRN complex has a corner-
stone function in DSB-induced signaling as it interacts with ataxia tel-
angiectasia-mutated (ATM) protein and thereby can activate
pathways leading to HRR, NHEJ, and microhomology-mediated end
joining. Additionally, the MRN complex also plays a role in the mainte-
nance of the telomeres and acts as a stabilizer at replication forks
(Lavin, Kozlov, Gatei, & Kijas, 2015; Stingele, Bellelli, & Boulton, 2017;
Williams, Lees-Miller, & Tainer, 2010).
So far, mutations in all three components of the MRN complex
have been reported in humans. Mutations in the NBN (NBS1) gene are
associated with Nijmegen breakage syndrome (NBS, OMIM
#251260), a disorder characterized by progressive microcephaly, mild
to moderate short stature, dysmorphic facial features including a
prominent nasal bridge and nose, sloping forehead, large ears, and
retrognathia. Furthermore, patients with NBS present with premature
ovarian insufficiency, immunodeficiency with recurrent pulmonary
infections and increased risk of malignancies within the second
decade of life. On a cellular level, chromosomal instability mostly
involving Chromosomes 7 and 14, and abnormal radioresistant DNA
synthesis of cultured cells can be observed (Chrzanowska et al., 1995;
Varon, Demuth, & Chrzanowska, 1993).
Mutations in MRE11A have been identified in patients with an
ataxia-telangiectasia-like disorder (ATLD Type 1, OMIM #604391).
These present with progressive cerebellar ataxia, atrophy of cerebellar
vermis and hemispheres, abnormal eye movements (oculomotor
apraxia), and dysarthria as key features (Delia et al., 2004; Fernet et
al., 2005; Fievet et al., 2019; Palmeri et al., 2013; Stewart et
al., 1999). Abnormal radiosensitivity of cell cultures has been reported.
In contrast to ataxia-telangiectasia (AT, OMIM #208900), patients
with ATLD have no telangiectasia, no myelodysplasia and have normal
immunoglobulin levels.
So far, only one patient with biallelic mutation in RAD50 has been
reported presenting with clinical features that partly resemble both,
NBS and ATLD (Barbi et al., 1991; Waltes et al., 2009), OMIM
#613078. Waltes et al. described a 23-year-old woman with com-
pound heterozygosity for mutations in RAD50 leading to a RAD50
protein deficiency. She showed dysmorphic facial features similar to
NBS, short stature, microcephaly, and mild/moderate intellectual
disability. Fibroblasts established from this patient showed chromo-
somal instability and abnormal radioresistant DNA synthesis. How-
ever, unlike NBS, this patient never developed severe infections. She
had normal immunoglobulin levels and no malignancies were reported.
Waltes et al. classified this disorder as a NBS-like disorder. In this
study, we describe a long-term follow-up of a second patient with
homozygosity for a novel RAD50 variant, and we show pathogenicity
of the identified variant and characterize the distinctive clinical phe-
notype of patients with RAD50 mutations.
2 | METHODS
2.1 | Genetic analysis
G-banded chromosome analysis was performed according to routine
standard procedures and genomic arrays were performed as previ-
ously described (van Zutven et al., 2018). DNA was isolated by stan-
dard procedures from blood leukocytes. Nucleotides were numbered
according to the Human Genome Variation Society guidelines. We
performed whole-exome sequencing (WES) on DNA extracted from
blood lymphocytes of the affected index patient using the Agilent
Sure Select Human All Exon 50 Mb enrichment kit. WES data analysis
and filtering of variants were carried out as previously described
(Bogershausen et al., 2015). RT-PCR was performed as described by
Vandervore et al. (2019).
2.2 | Radioresistant DNA synthesis
Fibroblasts from our patient, a patient with AT and a control patient
were isolated and DNA synthesis was measured as reported by de
Wit, Jaspers, and Bootsma (1981). In short, cells were prelabeled with
thymidine [14C] and irradiated with γ-radiation at 5, 10, 15, and 20 Gy
and then labeled with thymidine [3H]. An ice-cold phosphate buffered
saline was used to stop incubation. The ratio between 3H and 14C was
used as a measure of DNA syntheses. DNA synthesis of unirradiated
cells was used as baseline.
2.3 | Immunoblotting
Skin fibroblasts from our new patient (F583) were tested for their pro-
tein expression of RAD50 by immunoblotting following a lysis proto-
col previously described (Waltes et al., 2009) and compared with
large-T immortalized fibroblast lines from the previously reported
patient with RAD50 deficiency (F239-T) and from a healthy control
(ADD-T) (Schroder-Heurich, Wieland, Lavin, Schindler, & Dork, 2014).
Protein extracts were separated through SDS-PAGE followed by
immunoblotting. The antibodies used were RAD50 (mouse monoclo-
nal, Abcam, 1:500); MRE11A (mouse monoclonal 12D7, GeneTex,
1:1,000); NBN (rabbit polyclonal NB100-143, Novus, 1:5,000); and
β-actin (mouse monoclonal AC15, Sigma, 1:3,000). To assess the
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F IGURE 1 Clinical phenotype and pedigree. (a–d) Photographs of the facial features of the index patient at 10 months and 10 years old.
Dysmorphic features at 10 months include a broad nose with depressed nasal bridge, hypertelorism, mild upslant of eyelids, a small lower lip,
micrognathia, low implanted and rotated ears, and a short neck. At 10 years her features slightly changed, she had a prominent nose bridge with a
long nose point and a sloping forehead. (e,f) Photographs from hands and feet show bilateral clinodactyly of the fingers and toes, bilateral
transverse palmar crease, bilateral brachydactyly and a sandal gap. (g) Midsagittal T1 weighted images show normal development of midline brain
structures, including corpus callosum, pituitary stalk, gyration, and cerebellum. The cerebellar tonsils, however, show herniation in the foramen
magnum (Chiari malformation) and the medulla shows a (swan neck-like) kink associated by an abnormal position and morphology of the C2
vertebra. Signal intensity of the medulla and spinal cord are normal. (h–j) Growth data of the index patient. Weight (h), length (i), and
occipitofrontal circumference (j) all below −2 SD. (k, l) Hand and feet X-rays of the index patient at 6 months old. X-rays of the hands show short
mild phalanges of all digits and short phalanges of the first digits on both hands. X-rays of the feet shows short proximal phalanges of the first
digits of both feet (Type A1 brachydactyly of Bell). In addition, the middle phalanges of the fifth digits on both hands are missing. (m) Family
pedigree. Our proband is VI-2. Filled symbols indicate homozygosity for RAD50 mutation; left lower quadrant filled symbols indicate Seckel
disease (proband's niece, VI-1); right upper quadrant filled symbols indicate colon carcinoma and right lower quadrant filled symbol indicates lung
carcinoma [Color figure can be viewed at wileyonlinelibrary.com]
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cellular ability of radiation-induced damage recognition and ATM acti-
vation, we irradiated the fibroblasts with 6 Gy using a Mevatron MD-
2 accelerator (Siemens, Munich, Germany). Whole cell lysates were
extracted at 30 min after irradiation and immunoblotting was per-
formed against two targets of the ATM kinase, CHEK2(pSer19), and
KAP1(pSer824) as previously described (Pietrucha et al., 2017). The
antibodies used were pSer19-CHEK2 (rabbit polyclonal, Cell Signaling,
1:500) and pSer824-KAP1 (rabbit polyclonal, Bethyl Laboratories,
1:5,000). Anti-mouse and anti-rabbit horseradish peroxidases labeled
secondary antibodies were purchased from GE Healthcare. Enhanced
chemiluminescence (Dura ECL, Thermo Scientific/Pierce) was used for
visualization of immunoreactive bands.
2.4 | Editorial policies, ethical considerations, and
data availability statement
This study was conducted in accordance to the Helsinki Declaration
and was approved by the ethics committee of the University of
Cologne, Germany, and the ethics committee of the University Medi-
cal Center Göttingen, Germany. Informed written consent for
reviewing medical records and publication of pictures was obtained
from our proband and her parents. The data that support the findings
of this study, including the RT-PCR primer sequences, are available
upon request. The genomic data are not publicly available due to pri-
vacy restrictions.
3 | RESULTS
3.1 | Clinical report
The index patient, a 15-year-old female, was born as the first child of
consanguineous Turkish parents. The family history refers that the
paternal aunt, who was married to a fourth degree relative, had a
daughter diagnosed with Seckel syndrome and presenting with
growth delay. No medical record of this girl could be retrieved, how-
ever, pictures made available by the family show overlapping facial
features to our index patient. During pregnancy, intrauterine growth
retardation was recorded. The girl was born at 37 weeks of gestation
with a birth weight of 1,520 g (−3.5 SD) and a head circumference of
29.5 cm (−3.5 SD). At birth, dysmorphic features were noted. Physical
examination at 10 months of age revealed a broad nose with
depressed nasal bridge, hypertelorism, mild upslanting eyelids with
epicanthus inversus, a small lower lip, micrognathia, low implanted
and rotated ears, a short neck, wide spaced nipples, bilateral
clinodactyly of fingers and toes, bilateral transverse palmar crease,
bilateral brachydactyly, a sandal gap, multiple café-au-lait macules,
and high pitched cry (Figure 1a–f). Neonatal screening revealed hypo-
thyroidism due to transient hypothyroxinemia as a result of
dysmaturity. A normal female type karyotype was reported with no
evidence for spontaneous chromosomal breakages. Metabolic and
infectious screenings were normal. Her growth parameters remained
below the −3 SD during her first year of age and she had feeding diffi-
culties and gastroesophageal reflux. X-rays of hands and feet at the
age of 6 months and a complete skeletal survey at the age of 2 years
revealed hypoplasia of the second and terminal phalanges of the fifth
digit, mild valgus shape of both acetabula and normal proportion of
long bones (Figure 1k,l). Because of her low weight, reflux and low tol-
erance for oral food she was temporarily fed through a gastrostomy
tube. The growth hormone production and full endocrine screening
were normal. The total level of immunoglobulins and the subclasses
screening were normal in two occasions; no AFP test was performed.
She showed some improvement in her weight/height ratio, but the
height continued to follow the −6 SD; therefore, tube feeding was dis-
continued (Figure 1h–j). During follow-up examinations, delay in
speech and in motoric functions was noted. At the age of 2 years, an
auditory brainstem response test showed bilateral sensorineural hear-
ing loss of 90 dB, for which she received hearing aids. Neurological
evaluation was normal except for high-pitched voice and nasal speech,
slightly brisk reflexes of the lower extremities and a slightly unstable
straight-line walk which was not observed at later examinations. A
brain MRI at the age of 13 years showed a narrow foramen magnum
with mild herniation of the cerebellar tonsils (Figure 1g). EEG was nor-
mal. Because of complains of fatigue a cardiovascular examination
was performed which lead to the identification of Wolff–Parkinson–
White anomalies without supraventricular tachycardia. At the last
examination at the age of 15 years, her height was 126.5 cm
(−5.8 SD) and head circumference 48.3 cm (−3.9 SD). A prominent
nose bridge with a long nose point, a sloping forehead, telecanthus, a
short neck, and thoracic kyphosis were noted. Sexual development
had been normal with normal puberty and development of secondary
sexual characteristics. At age 15, her TIQ was estimated to be 85. She
currently lives with her parents and attends a special school for chil-
dren with hearing loss. No decline of intellectual or motor functions
has been observed. She has good communication skills and neither
had any severe or recurrent infections nor malignancies.
3.2 | Genetic analysis
Genomic microarrays revealed a normal female hybridization pattern
and included several regions of homozygosity reflecting parental con-
sanguinity. Exome sequencing did not identify homozygous or com-
pound heterozygous variants in any of the OMIM-referenced genes
associated with autosomal recessive isolated or syndromic forms of
primary microcephaly. Therefore, we subsequently filtered WES data
for rare (minor allele frequency [MAF] <0.5% in the 1,000 Genomes
database and the Exome Variant Server (EVS; NHLBI Exome Sequenc-
ing Project [ESP])), homozygous (allele frequency ≥75%) variants.
Among the variants identified, only one variant was predicted to have
a severe impact of protein function. In Exon 15 of RAD50, we identi-
fied homozygosity for the alteration c.2524G > A located at the last
base of this exon and predicted to disrupt the adjacent donor splice
splice site. This variant was embedded within the largest homozygous
stretch of 22.6 Mb on chromosome 5q which was identified in this
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patient based on the WES data. Both parents were heterozygous car-
riers for the identified c.2524G > A variant in RAD50 which was nei-
ther annotated as a common single nucleotide polymorphism, nor
found in >13,000 exomes within the EVS (National Heart, Lung, and
Blood Institute ESP, Seattle, WA). This variant was identified with a
MAF of 1.072e-4 in the gnomAD database (access date July 10,
2019), but only in the heterozygous state. As the c.2524G > A variant
affects the last base of exon 15 and was predicted to disrupt the adja-
cent donor splice site, we analyzed the effect of this variant on splic-
ing of RAD50 mRNA, isolated from skin fibroblasts derived of the
index patient, by RT-PCR and subsequent Sanger sequencing. We
could show that the c.2524G > A variant leads to a major transcript
that is generated by complete skipping of exon 15 of RAD50, there-
fore predicted to induce a frameshift and premature protein trunca-
tion (RAD50 p.Met800Phefs*7) (Figure 2a). Additionally, we observed
a correctly spliced minor transcript variant carrying the p.Val842Ala
amino acid substitution predicted from the c.2524G > A missense
variant.
3.3 | Radioresistant DNA synthesis
Considering that RAD50 forms a complex with NBS and MRE11
which then recruits ATM at the sites of DSBs, we tested whether
downregulation of DNA synthesis normally occurring after gamma
irradiation was intact in cells harboring the RAD50 mutation, or if this
process is suppressed, as observed in cells lacking ATM. Exposure of
wild-type fibroblasts to radiation halted DNA synthesis in these cells
as shown in Figure 2b as percentage relative to DNA synthesis under
no radiation. However, treatment of skin fibroblasts derived from our
proband lead to radioresistant DNA synthesis almost similar to fibro-
blasts derived from an individual with AT indicating that, similarly to a
F IGURE 2 Genetic analysis, DNA synthesis, and ataxia telangiectasia-mutated (ATM) signaling. (a) RT-PCR analysis of RAD50. Schematic
representation of the amplified region of RAD50 cDNA and locations of primers used for the amplification (upper panel). The black arrow
indicates the position of the primers used for amplification, the gray arrow indicated the position of the c.2524G > A mutation in exon 15. RT-
PCR analysis of RAD50 in the patient showed two different transcripts: one alternative transcripts of smaller size, and one transcript of
corresponding size compared to WT (lower panel). Sequencing of the smaller RT-PCR products derived from patient cDNA revealed that the
c.2524G > A mutation mainly resulted in a splicing product characterized by exon 15 skipping inducing a frameshift and premature protein
truncation (RAD50 p.Met800Phefs*7). (b) DNA synthesis after exposure to γ-radiation in fibroblasts of our patient (lozenge symbol), a patient
with ataxia telangiectasia (square), and control individual (triangle) as percentage of DNA synthesis at no exposure to radiation. (c) Whole cell
protein lysates of fibroblasts from a healthy donor (ADD-T), from the patient described in this study (F583) and from the previously reported
patient with RAD50 deficiency (F239-T) were comparatively assessed for RAD50 protein levels (upper panel) and for the radiation-induced
phosphorylation of the ATM targets CHEK2 (pSer19) and KAP1 (pSer824) (lower panel). Cells had been irradiated with 0, 1.5, or 6 Gy as
indicated, and proteins had been extracted at 30 min after irradiation. RAD50 immunoreactivity is shown at different exposure times (labeled as
“low” and “high”). β-actin served as a loading control [Color figure can be viewed at wileyonlinelibrary.com]
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mutation in ATM, the identified c.2524G > A variant in RAD50
induces radioresistant DNA synthesis.
3.4 | RAD50 protein levels and ATM signaling
The effects of the c.2524G > A variant on RAD50 protein levels and
on radiation-induced ATM signaling were further investigated by
immunoblotting after irradiation of the fibroblasts with 0, 1.5, or 6 Gy
(Figure 2c). RAD50 protein was almost undetectable in the F583
fibroblasts, even after long exposure times at which fibroblasts from
the previously reported RAD50-deficient patient (F239-T) showed
traces of RAD50 protein. We additionally assessed the levels of the
other two MRN complex members, MRE11A and NBN, and found a
strong reduction for both these proteins that was even more pro-
nounced in the F583 fibroblasts than in F239-T cells (Figure S1). Simi-
larly, the phosphorylation of the known ATM kinase targets CHEK2
and KAP1 was absent at 1.5 Gy and was barely detectable at 6 Gy of
irradiation which was consistent with a marked deficiency in radia-
tion-induced DNA damage signaling (Figure 2c).
4 | DISCUSSION
We report a girl of Turkish descent with a distinct phenotype carrying
a novel homozygous variant in the RAD50 gene. This variant,
c.2524G > A in exon 15 of RAD50, affects the last base at exon 15
and we could show that it disrupts the adjacent donor splice site
inducing skipping of this exon and resulting in a frameshift, premature
protein truncation and most likely, loss of RAD50 function.
To date, only one individual with biallelic RAD50 mutations has
been reported (Barbi et al., 1991; Waltes et al., 2009). A comparison
of the features of our patient, the previously reported patient and
patients with NBS is summarized in Table 1. Both RAD50 subjects
were small for gestational age and microcephalic at birth, had similar
dysmorphic facial features, postnatal short stature, and progressive
microcephaly. Both individuals had normal sexual development, no
hormonal deficiencies, mild learning disability, and no decline in intel-
lect, or psychomotor functions. Cultured fibroblasts from both individ-
uals displayed abnormal radioresistant DNA synthesis after gamma-
radiation and severe reduction of RAD50 protein on immunoblots.
Evidence of spontaneous chromosome instability was observed in the
first reported individual, but the karyotype and genomic copy number
in leukocytes of our patient were normal. Both girls show no sign of
immunodeficiency or recurrent infections, which are associated with
NBS and also with the NBS-like disorders, NHEJ1 deficiency, and
LIG4 deficiency (Altmann & Gennery, 2016; Dutrannoy et al., 2010;
Varon et al., 1993). At the time of writing, no malignancies are
reported.
Human RAD50 deficiency belongs to the spectrum of MRN-
related disorders. This clinical continuum also includes NBS and ATLD
Type 1. Based on the clinical characterization of the index patient
described herein and the comparison with the previously reported
patient, we are now able to determine distinctive phenotype features
resulting from RAD50 mutations. Compared to ATLD Type 1, individ-
uals with RAD50 mutations do not present with strong neurological
signs or symptoms, nor signs of neurodegeneration and with only mild
learning disabilities.
ATLD Type 1 is caused by mutations in MRE11A and it has been
associated with progressive cerebellar ataxia. However, biallelic
MRE11A mutations have also been reported in two unrelated individ-
uals sharing severe primary microcephaly, moderate to severe intellec-
tual disability and pyramidal signs, but no cerebellar atrophy, nor
immunodeficiency (Matsumoto et al., 2011). The authors define this
disorder as a Nijmegen breakage-like syndrome. Similarly, RAD50
mutations have also been classified as causing a Nijmegen breakage-
like syndrome, and indeed, there is phenotypical overlap to individuals
with NBS (Varon et al., 1993). We also note that the segregation pat-
tern in this family, including heterozygous parents and one niece iden-
tified with a diagnosis of Seckel syndrome, is supportive of an
autosomal recessive microcephaly syndrome (Figure 1m).
Still, the main difference between RAD50-related syndrome and
“classic” NBS caused by NBN mutations is the absence of reported
sensitivity to infections and increased risk of malignancies (Varon et
al., 1993). Commonalities are mostly in the severe growth retardation
already present in utero, the congenital microcephaly, the mild/mod-
erate ID, and global similar dysmorphism. However, in most cases of
NBS, there is a progressive microcephaly and a progressive growth
improvement, leading to more evident disproportion with increasing
age. This type of progression does not seem to apply for the patient
with RAD50 mutations in our study. Thus, although this syndrome
does represent a NBS-like disorder, we prefer the name of RAD50
deficiency to account for these clinical differences and to distinguish
it from other NBS-like disorders.
Waltes et al. also reported a heterozygous state for the rare vari-
ant c.506G > A, p.Arg169His (rs776134250), in NBN in their individ-
ual with biallelic RAD50 mutations. In the patient described here, no
such NBN variant was detected in the exome sequencing, confirming
that the clinical phenotype essentially results from the RAD50 muta-
tion. This also implies that the observed instability of the partner pro-
teins in the MRN complex, MRE11A and NBN, results from the
RAD50 deficiency. A similar destabilization of all three members of
the MRN complex has been reported in ATLD Type 1 patients (Delia
et al., 2004; Fievet et al., 2019; Stewart et al., 1999). It is possible that
the residual levels of these three proteins to some degree modulate
the clinical phenotype in a tissue-specific manner.
An increasing number of children are presumably going to be
diagnosed through whole-exome sequencing, meanwhile no manage-
ment guidelines exist for RAD50-related disorder. Currently, it is
unknown if patients with RAD50 mutation have an increased risk of
developing malignancies. However, two cases of colon carcinoma and
one case of lung carcinoma were found within the family of our index
patient (Figure 1m). Therefore, it is advisable to manage individuals
with the RAD50-related disorder similarly to NBS individuals, as we
cannot exclude that also RAD50 mutation increases the risk of malig-
nancies. We recommend, after initial diagnosis, consultation of a
6 RAGAMIN ET AL.
TABLE 1 Overview of clinical and genetic features RAD50-related syndrome and NBS
Individual 1 (Barbi
et al., 1991; Waltes
et al., 2009) Individual 2 (this report)
NBS (Chrzanowska
et al., 1995; Nijmegen
breakage syndrome, 2000;
Varon et al., 1993)
Sex Female Female Both
Ethnicity German Turkish Mostly associated with
western Slavic
Age 23a 15a
Mutation c.3277C! T
c.3939A! T
Homozygous
c.2524G > A
Inactivating variants in NBN
(Nibrin), most common
c.657-661del5
Protein change and expression level p.(Arg1093*) and p.
X1313TyrextX*66
p.(Met800Phefs*7) and
low-level p.(Val842Ile)
Several
Clinical manifestations
Gestational age (weeks) 40 37 Normal
Birth weight (g) 1,835 (<−2.5 SD) 1,520 (<−3.5 SD) <−2SD to normal
Birth head circumference (cm) 26.5 (<−6.5 SD) 29.5 (<−3.5 SD) Microcephalic to normal
Birth body length (cm) 41 (<−4 SD) 36 (<−7.5 SD) Often IUGR
Distinctive phenotype
Sloping forehead + + +
Broad nasal bridge + + +
Prominent eyes + − +
Epicanthal folds + − Common
Widely spaced nipples + + −
Hypoplastic nasal septum + + +
Bilateral clinodactyly + + Common
Brachydactyly N. d. + −
Sandal gap N. d. + Common
Cutaneous vascular anomalies + + Occasionally
Hyperpigmentation and hypopigmentation + + Common
Neurological symptoms Very rare
Reflex Normal Normal
High pitched voice N. d. +
Hyperopia + −
Sensorineural hearing loss N. d. +
Ataxia Subtle unstable
straight-line walk
− −
Immunology
Recurrent infections − − +
Ig status Normal Normal Low IgG and IgA
Lymphocyte counts Normal Normal Low T cells
Cellular features
Chromosome instability + (normal karyotype) +
Radioresistant DNA synthesis + + +
Clinical manifestations
Age 23 years 15 years
Height (cm) 130 (<−4.5 SD) 126.5 (<−5 SD) Growth retardation
Weight (kg) 29 (<−3 SD) 25.3 (<−3.5 SD) Growth retardation
Head circumference (cm) 43 (−10 SD) 48.3 (<−5 SD) Microcephaly
NBS-like facial features + + +
(Continues)
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clinical geneticist, assessment of growth, immunologic state, and cog-
nitive development. As applied in other syndromes associated with
primordial dwarfism, overfeeding should be avoided and growth hor-
mone supplementation should only be restricted to cases with proven
GH deficiency. Puberty and development of secondary sexual charac-
teristics should be carefully monitored and if needed, endocrine evalu-
ation and pelvic ultrasound should be performed. Because of
abnormal radioresistant DNA synthesis, we would advise against
repeated radiographs or CT scan and instead suggest using diagnostic
MRI or ultrasound where consistent with the medical indication.
Clearly, further research and identification of more patients will be
required to guide the clinical management of RAD50 deficiency.
5 | CONCLUSION
We report a second individual with biallelic RAD50 mutation con-
firming the association of RAD50 dysfunction with a distinctive
phenotype. Based on our patient and the previously reported case,
RAD50 deficiency should be considered as a separate disease
entity, within the MRN-related disorders, with facial features
resembling NBS, that is, severe prenatal growth retardation and
persistent postnatal growth restriction, congenital microcephaly,
mild to borderline intellectual disability, normal sexual develop-
ment, radioresistant DNA synthesis, and no immunodeficiency or
myelodysplasia or early neurodegeneration as key features. We
encourage description of additional cases to delineate adequate
management advice.
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